Primary Care, Events
21 results
Applied filters
SMRs in problematic polypharmacy: antimicrobial focus
12 May 2026Expert pharmacists used case studies to illustrate a patient centred approach to SMRs for patients on antimicrobials.
Primary care discussions: HRT use in clinical practice
24 April 2024This ‘on the couch’ webinar, the second in a series of two, addressed questions around the challenges faced by pharmacists with HRT decision making.
SMRs in problematic polypharmacy: insomnia focus
14 April 2026Expert pharmacists used a case study to illustrate a patient centred and holistic approach to SMRs for patients prescribed medicines for insomnia.
SMRs in problematic polypharmacy: cardiovascular disease focus
10 March 2026Consultant pharmacists used a case study to illustrate a patient centred approach to SMRs for patients with cardiovascular disease.
Personalising evidence-based medicine to reduce polypharmacy
11 February 2025An insight on principles of patient centred structured medication reviews; using the current evidence and shared decision making to facilitate de-prescribing.
Personalised evidence-based medicine to minimise polypharmacy
4 March 2025A consultant pharmacist used case studies to illustrate a patient-centered approach to deprescribing in patients with problematic polypharmacy.
SMRs in problematic polypharmacy: respiratory focus
13 January 2026Consultant pharmacists used a case study to illustrate a patient centred approach to SMRs for patients with respiratory conditions.
SMRs in problematic polypharmacy: diabetes focus
10 February 2026Consultant pharmacists used a case study to illustrate a patient centred approach to SMRs for patients with diabetes.
Primary care discussions: Hypertension care in community pharmacy
2 December 2025A community pharmacist, GP, and primary care team share how blood pressure management has strengthened Access and Recovery services and improved patient care.
Primary care discussions: biosimilar insulin
30 September 2025Discussion about the considerations of implementing biosimilar insulin in primary care. Hints and tips for systems considering a move to biosimilar insulin.